A comprehensive review of the latest Indian guidelines on adult immunization
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20250339Keywords:
API guidelines, Adult immunization, COVID-19 booster, Hepatitis B vaccine, Herpes zoster vaccine, Influenza vaccine, Public health, Pneumococcal vaccineAbstract
This review consolidates the most recent guidelines on adult immunization issued by the Association of Physicians of India (API) in 2024. The guidelines underscore the importance of immunization in adults, particularly considering the growing geriatric population, projected to make 20% of the population by 2050. Key recommendations include the administration of vaccines for influenza, pneumococcus, hepatitis B and herpes zoster, with specific emphasis on high-risk groups such as healthcare workers, the elderly and individuals with chronic conditions. Additionally, the guidelines highlight the necessity of COVID-19 vaccinations and boosters, considering the emergence of new variants. The API guidelines provide a detailed framework for vaccination schedules, prioritizing clarity and practical implementation for healthcare providers managing patients with multiple co-morbidities. By offering a consolidated and evidence-based approach, these guidelines aim to enhance vaccination coverage and protect against vaccine-preventable diseases in the adult population.
Metrics
References
Immunization Agenda 2030. Available at: https://www.who.int/teams/immunization. Accessed on 21 August 2025.
Mathur G, Vora A. Indian Consensus Guideline on Adult Immunization. Available at: https://www.emvac.in. Accessed on 21 August 2024.
Ram B, Thakur R. Epidemiology and Economic Burden of Continuing Challenge of Infectious Diseases in India: Analysis of Socio-Demographic Differentials. Front Public Health. 2022;10:901276. DOI: https://doi.org/10.3389/fpubh.2022.901276
Kolobova I, Nyaku MK, Karakusevic A, Bridge D, Fotheringham I, O’Brien M. Burden of vaccine-preventable diseases among at-risk adult populations in the US. Hum Vaccin Immunother. 2020;18:2054602. DOI: https://doi.org/10.1080/21645515.2022.2054602
Koul PA, Chaudhari S, Chokhani R, Christopher D, Dhar R, Doshi K, et al. Pneumococcal disease burden from an Indian perspective: Need for its prevention in pulmonology practice. Lung India. 2019;36:216–25. DOI: https://doi.org/10.4103/lungindia.lungindia_497_18
Ramamoorthy T, Sathishkumar K, Das P, Sudarshan KL, Mathur P. Epidemiology of human papillomavirus related cancers in India: findings from the National Cancer Registry Programme. E Cancer Medical Science. 2022;16:1444. DOI: https://doi.org/10.3332/ecancer.2022.1444
Socio-Economic Value of Adult Immunisation Programmes - OHE. OHE - Leading intellectual authority on global health economics. 2024. Available at: https://www.ohe.org/publications. Accessed on 12 August 2025.
Faujdar DS, Kaushik SK, Sharma P, Yadav AK. Need to Study the Health Impact and Economics of Adult Vaccination with India in Focus. Indian J Community Med. 2022;47:471–5. DOI: https://doi.org/10.4103/ijcm.ijcm_1333_21
Ayyalasomayajula S, Dhawan A, Karattuthodi MS, Thorakkattil SA, Abdulsalim S, Elnaem MH, et al. A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population. Vaccines. 2023;11:623. DOI: https://doi.org/10.3390/vaccines11030623
Kalra N, Kalra T, Mishra S, Basu S, Bhatnagar N. Hesitancy for adult vaccines among healthcare providers and their family members in delhi, india: a cross-sectional study. Dialogues in Health. 2022;1:100044. DOI: https://doi.org/10.1016/j.dialog.2022.100044